Research & Development
USPSTF: Pregnant women may not need vaginosis screening
The recommendation updates the task force's 2008 guideline with a further literature review but is not different, wrote a team led by USPSTF chair Dr. Douglas Owens of Stanford University. The group found that bacterial vaginosis screening just doesn't seem to offer an advantage for avoiding preterm delivery, which has been associated with the condition.
April 7, 2020
Can cheap test prevent newborn deaths? | Amino acid desmosine as biomarker in aneurysms | Brouhaha over DTC genetic tests
Dear LabPulse Member,
October 21, 2019
NIH study finds vaginal bacteria could predict preterm births
A research group led by Jennifer Fettweis, PhD, of Virginia Commonwealth University analyzed data from a subpopulation of over 1,500 women who participated in the NIH Common Fund's Human Microbiome Project. The researchers collected samples of vaginal bacteria from 45 pregnant women who delivered their babies preterm and compared them with samples from 90 women who delivered at full term. Almost 80% of the 135 women were African American.
May 29, 2019
FDA clears 2 Hologic tests for yeast infections
Hololgic's Aptima BV test is for bacterial vaginosis (BV), and the Aptima CV/TV assay is designed for detecting Candida vaginitis (CV) and Trichomomas vaginalis (TV). These three are the most common types of vaginitis, accounting for 90% of cases, and coinfection is common, the company noted.
May 28, 2019
Quest launches long-COVID testing panels for consumers
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for millions of dollars in unnecessary urinalysis testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Patients prefer immediate test results, even when the news is bad
Quest Diagnostics offers suite of services for transplant patients and living donors
Page 1 of 1